Achillion Pharmaceuticals Stock Analysis
Technical stock analysis for 22 January 2019
Achillion Pharmaceuticals fell by -3.65% in the last day from $2.19 to $2.11 and has now fallen 3 days in a row. The price has risen in 5 of the last 10 days and is up by 6.03% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.37 million shares and in total 1.79 million shares bought and sold for approximately $3.78 million.
Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the ACHN stock was $2.11. This is 3.65% less than the trading day before Friday, 18th Jan 2019.
During day the stock fluctuated 7.28% from a day low at $2.06 to a day high of $2.21.
30 day high of the ACHN stock price was $2.44 and low was $1.31.
90 day high was $3.30 and low was $1.29.
52 week high for the Achillion Pharmaceuticals - $4.34 and low - $1.29.
Achillion Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.82% during the next 3 months and, with 90% probability hold a price between $0.56 and $1.70 at the end of this period.
There are few to none technical positive signals at the moment. Achillion Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.16 and $2.23. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 17, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
The stock holds a RSI14 at 74 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $1.95 and $1.65.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Achillion Pharmaceuticals finds support just below today's level at $1.95. If this is broken, then the next support from accumulated volume will be at $1.65 and $1.64.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.15 between high and low, or 7.28%. For the last week, the stock has had a daily average volatility of 8.75%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Achillion Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.
|ACHN $2.11 $-0.08(-3.65%)|
ACHN is down $0.08 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACHN based on the 1-3 month system that more than doubles the S&P 500.
Click here – the ACHN analysis is free »